This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugai, M.
Right arrow Articles by Suginaka, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugai, M.
Right arrow Articles by Suginaka, H.

 Previous Article  |  Next Article 

J. Bacteriol., 07 1997, 4311-4318, Vol 179, No. 13
Copyright © 1997, American Society for Microbiology

epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus

M Sugai, T Fujiwara, K Ohta, H Komatsuzawa, M Ohara and H Suginaka
Department of Microbiology, Hiroshima University School of Dentistry, Minami-ku, Japan. sugai@ipc.hiroshima-u.ac.jp

Staphylococcus capitis EPK1 produces a glycylglycine endopeptidase, ALE- 1 (M. Sugai, T. Fujiwara, T. Akiyama, M. Ohara, H. Komatsuzawa, S. Inoue, and H. Suginaka, J. Bacteriol. 179:1193-1202, 1997), which hydrolyzes interpeptide pentaglycine chains of cell wall peptidoglycan of S. aureus. Characterizations of the enzyme activity and cloning of ale-1 revealed that ALE-1 is very similar to prolysostaphin produced by S. simulans bv. staphylolyticus. Strain EPK1 is resistant to lysis by ALE-1 and by lysostaphin. A gene that renders the cells resistant to glycylglycine endopeptidase (epr) was found 322 bp upstream of and in the opposite orientation to ale-1. The deduced amino acid sequence of epr showed similarities to FemA and FemB, which have been characterized as factors essential for methicillin resistance of S. aureus. Inactivation of either femA or femB causes decreased resistance to methicillin, increased resistance to lysostaphin, and decreased glycine content in the interpeptide chains of peptidoglycan. Therefore, femAB is suggested to be involved in the addition of glycine to pentapeptide peptidoglycan precursor. S. aureus with epr on a multicopy plasmid had phenotypes similar to those of femAB mutants except that it did not alter resistance level to methicillin. These results suggest that epr and femAB belong to the protein family involved in adding amino acids to the pentapeptide peptidoglycan precursor and that epr is involved in the addition of serine to the pentapeptide.


This article has been cited by other articles:

  • Gargis, S. R., Gargis, A. S., Heath, H. E., Heath, L. S., LeBlanc, P. A., Senn, M. M., Berger-Bachi, B., Simmonds, R. S., Sloan, G. L. (2009). Zif, the Zoocin A Immunity Factor, Is a FemABX-Like Immunity Protein with a Novel Mode of Action. Appl. Environ. Microbiol. 75: 6205-6210 [Abstract] [Full Text]  
  • Kusuma, C., Jadanova, A., Chanturiya, T., Kokai-Kun, J. F. (2007). Lysostaphin-Resistant Variants of Staphylococcus aureus Demonstrate Reduced Fitness In Vitro and In Vivo. Antimicrob. Agents Chemother. 51: 475-482 [Abstract] [Full Text]  
  • Lu, J. Z., Fujiwara, T., Komatsuzawa, H., Sugai, M., Sakon, J. (2006). Cell Wall-targeting Domain of Glycylglycine Endopeptidase Distinguishes among Peptidoglycan Cross-bridges. J. Biol. Chem. 281: 549-558 [Abstract] [Full Text]  
  • Shaw, L. N., Golonka, E., Szmyd, G., Foster, S. J., Travis, J., Potempa, J. (2005). Cytoplasmic Control of Premature Activation of a Secreted Protease Zymogen: Deletion of Staphostatin B (SspC) in Staphylococcus aureus 8325-4 Yields a Profound Pleiotropic Phenotype. J. Bacteriol. 187: 1751-1762 [Abstract] [Full Text]  
  • Rohrer, S., Berger-Bachi, B. (2003). FemABX Peptidyl Transferases: a Link between Branched-Chain Cell Wall Peptide Formation and {beta}-Lactam Resistance in Gram-Positive Cocci. Antimicrob. Agents Chemother. 47: 837-846 [Full Text]  
  • Kerr, D. E., Wellnitz, O. (2003). Mammary expression of new genes to combat mastitis. J ANIM SCI 81: 38-47 [Abstract] [Full Text]  
  • Reinscheid, D. J., Stosser, C., Ehlert, K., Jack, R. W., Moller, K., Eikmanns, B. J., Chhatwal, G. S. (2002). Influence of proteins Bsp and FemH on cell shape and peptidoglycan composition in group B streptococcus. Microbiology 148: 3245-3254 [Abstract] [Full Text]  
  • Kiri, N., Archer, G., Climo, M. W. (2002). Combinations of Lysostaphin with {beta}-Lactams Are Synergistic against Oxacillin-Resistant Staphylococcus epidermidis. Antimicrob. Agents Chemother. 46: 2017-2020 [Abstract] [Full Text]  
  • Beukes, M., Hastings, J. W. (2001). Self-Protection against Cell Wall Hydrolysis in Streptococcus milleri NMSCC 061 and Analysis of the Millericin B Operon. Appl. Environ. Microbiol. 67: 3888-3896 [Abstract] [Full Text]  
  • Ehlert, K., Tschierske, M., Mori, C., Schröder, W., Berger-Bächi, B. (2000). Site-Specific Serine Incorporation by Lif and Epr into Positions 3 and 5 of the Staphylococcal Peptidoglycan Interpeptide Bridge. J. Bacteriol. 182: 2635-2638 [Abstract] [Full Text]  
  • Rohrer, S., Ehlert, K., Tschierske, M., Labischinski, H., Berger-Bachi, B. (1999). The essential Staphylococcus aureus gene fmhB is involved in the first step of peptidoglycan pentaglycine interpeptide formation. Proc. Natl. Acad. Sci. USA 96: 9351-9356 [Abstract] [Full Text]  
  • Navarre, W. W., Schneewind, O. (1999). Surface Proteins of Gram-Positive Bacteria and Mechanisms of Their Targeting to the Cell Wall Envelope. Microbiol. Mol. Biol. Rev. 63: 174-229 [Abstract] [Full Text]  
  • Filipe, S. R., Pinho, M. G., Tomasz, A. (2000). Characterization of the murMN Operon Involved in the Synthesis of Branched Peptidoglycan Peptides in Streptococcus pneumoniae. J. Biol. Chem. 275: 27768-27774 [Abstract] [Full Text]